Nuwellis (NUWE) Short-term Investments (2021 - 2023)

Nuwellis (NUWE) posted Short-term Investments of $575000.0 for Q1 2023, up 1.05% on a QoQ basis from $569000.0 in Q4 2022.

Nuwellis (NUWE) Short-term Investments (2021 - 2023) Analysis & Trends

Nuwellis' Short-term Investments history runs 3 years deep, the most recent figure standing at $575000.0 for Q1 2023.

  • Quarterly Short-term Investments changed N/A year-over-year to $575000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $575000.0 (changed N/A YoY) and the FY2022 annual result came in at $569000.0, down 96.32% from the prior year.
  • Short-term Investments was $575000.0 for Q1 2023 at Nuwellis, up from $569000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $15.5 million in Q4 2021 and bottomed at $569000.0 in Q4 2022.
  • A 3-year average of $5.5 million and a median of $575000.0 in 2023 frame the typical range for Short-term Investments.
  • Peak annual rise in Short-term Investments reached 96.32% in 2022, while the deepest fall reached 96.32% in 2022.
  • Nuwellis' Short-term Investments stood at $15.5 million in 2021, then sank by 96.32% to $569000.0 in 2022, then gained by 1.05% to $575000.0 in 2023.
  • Business Quant data shows NUWE's Short-term Investments at $575000.0 in Q1 2023, $569000.0 in Q4 2022, and $15.5 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Nuwellis 613.80 -2.08 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 575,000.00
Dec 31, 2022 569,000.00
Dec 31, 2021 15.46 Mn